Improving Health Outcomes for Black Women and Girls With Disabilities
By Megan Buckles and Mia Ives-Rublee,
Center for American Progress
| 02. 15. 2022
Photo licensed for reuse under CC BY 4.0
Studies show that people with disabilities are more likely than people without disabilities to report having poorer health and less access to adequate health care.1 This is especially true for women and girls of color with disabilities, who face inequalities because of their disability status, race, and gender.2 The systemic and structural barriers faced by Black disabled women and girls in the health care system stem from a legacy of slavery, ongoing anti-Black racism, and ableism.
The COVID-19 pandemic exposed and exacerbated those inequalities. According to the Centers for Disease Control and Prevention, Black Americans are dying from COVID-19 at nearly twice the rate of white Americans and have hospitalization rates that are nearly three times higher.3 People with disabilities are also disproportionately contracting and dying from COVID-19.4
Data are more limited for people with intersecting identities. Specifically, there are insufficient data on the impact of COVID-19 on women—and even less on Black women and still less for Black women with disabilities. According to a study from January 2021,5 U.S...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...